Addex Therapeutics Ltd Interest Expense On Lease Liabilities
Addex Therapeutics Ltd (ADXN) reported Interest Expense On Lease Liabilities of CHF 495 for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseOnLeaseLiabilities · last filed 2025-09-30
- Addex Therapeutics Ltd interest expense on lease liabilities for the quarter ending 2025-06-30 was 495.00 CHF, a 15.93% increase year-over-year.
- Addex Therapeutics Ltd interest expense on lease liabilities for the quarter ending 2024-06-30 was 427.00 CHF, a 88.57% decline year-over-year.
- Addex Therapeutics Ltd interest expense on lease liabilities for the quarter ending 2023-06-30 was 3.73K CHF, a 21.50% decline year-over-year.
- Addex Therapeutics Ltd interest expense on lease liabilities for the quarter ending 2022-06-30 was 4.76K CHF, a 16.01% decline year-over-year.
| Period end | Interest Expense On Lease Liabilities 3 month | Interest Expense On Lease Liabilities 6 month | Interest Expense On Lease Liabilities 12 month | Interest Expense On Lease Liabilities 12 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | 495.00 CHF 6-K · filed 2025-09-30 | 1.01K CHF 6-K · filed 2025-09-30 | ||
| 2024-12-31 | 1.94K CHF 20-F · filed 2025-05-15 | |||
| 2024-06-30 | 427.00 CHF 6-K · filed 2025-09-30 | 892.00 CHF 6-K · filed 2025-09-30 | ||
| 2023-12-31 | 2.22K CHF 20-F · filed 2025-05-15 | 19.96K CHF 20-F · filed 2024-04-18 | ||
| 2023-06-30 | 3.73K CHF 6-K/A · filed 2023-12-21 | 9.65K CHF 6-K/A · filed 2023-12-21 | ||
| 2022-12-31 | 25.88K CHF 20-F · filed 2025-05-15 | 23.02K CHF 20-F · filed 2023-03-30 | ||
| 2022-06-30 | 4.76K CHF 6-K/A · filed 2023-12-21 | 10.38K CHF 6-K/A · filed 2023-12-21 | ||
| 2021-12-31 | 23.87K CHF 20-F · filed 2024-04-18 | |||
| 2021-06-30 | 5.67K CHF 6-K/A · filed 2022-09-14 | 12.28K CHF 6-K/A · filed 2022-09-14 | ||
| 2020-12-31 | 19.04K CHF 20-F · filed 2023-03-30 | |||
| 2019-12-31 | 22.60K CHF 20-F · filed 2022-03-10 |